Very interesting read! I do wonder, though, what benefit taking a retroviral cocktail would give over taking a MS disease-modifying drug. On its face, the drugs seem to accomplish the same thing. Future studies might show more differences. And, I disagree with one statement in the article: "Although treatments are available for the relapsing form of MS, none can halt the persistent progression seen later in the disease." I don't know when this study was published, but this claim sounds dated. As of today, 12/31/2023, in fact, MS disease-modifying drugs have been developed to treat PPMS and SPMS, not just RRMS. What's more, the claim that no RRMS drugs can halt the persistent progression seen later in the disease isn't accurate. PLwMS respond differently to these drugs, with many successfully: 1) stabilizing the patient's disease symptoms, 2) and drastically reducing or eliminating relapses all together. For me, the most interesting takeaway of the HIV retroviral drug study is the impact it might have on the Epstein-Barr virus. Precisely what role EBV has on the risk of developing active MS has started revealing itself in recent studies. Thank you, Anthonyp, for bringing this to our attention! Hugs, Kim